Omni Bio Pharmaceutical (OMBP) Stock Price, News & Analysis

Company Overview

Omni Bio Pharmaceutical, Inc. was a biotechnology company focused on developing therapeutic applications for alpha-1 antitrypsin (AAT), a naturally occurring human protein with anti-inflammatory and immune-modulating properties. The company’s research centered on using AAT-based therapies to address conditions associated with inflammation and tissue damage.

Omni Bio’s development activities included work on recombinant and inhaled forms of AAT, with potential applications in respiratory and other inflammatory diseases. Its programs were primarily research and development initiatives rather than a broad commercial product portfolio.

Publicly available information about Omni Bio Pharmaceutical’s current operations, leadership, geographic footprint and product commercialization is limited. The company has historically been associated with biotechnology research in the United States and was quoted on the over-the-counter market under the symbol OMBP.

Key Stats

• Today's Range: $0.0010 to $0.0010
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.04
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/16/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:OMBP
• CIK: 1389870
• Web: www.omnibiopharma.com
• Phone: 970-237-5178
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A